10X Genomics Inc (TXG) financials · rev $642.8M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
10X Genomics Inc (TXG) rev $642.8M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $642.8M | $610.8M |
| Cost of Revenue | $198.9M | $196.3M |
| Gross Profit | $443.9M | $414.5M |
| Operating Income | -$61.0M | -$194.6M |
| Net Income | -$43.5M | -$182.6M |
| EPS (Diluted) | -$0.35 | -$1.52 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.04B | $918.6M |
| Current Assets | $684.5M | $584.4M |
| Cash & Equivalents | N/A | $344.1M |
| Inventory | $56.3M | $83.1M |
| PP&E | $226.7M | $252.6M |
| Total Liabilities | $245.0M | $208.5M |
| Current Liabilities | $153.5M | $117.6M |
| Shareholders' Equity | $796.3M | $710.1M |
| Retained Earnings | -$1.51B | -$1.47B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $136.1M | $6.66M |
| CapEx | $5.93M | $12.4M |
| Investing Cash Flow | -$13.4M | -$32.6M |
| Financing Cash Flow | $6.80M | $10.9M |
| Net Change in Cash | $129.9M | -$15.2M |
| Free Cash Flow | $130.1M | -$5.73M |
FAQ
What is TXG P/E and revenue?
10X Genomics Inc (TXG) rev $642.8M.
What is TXG revenue?
10X Genomics Inc last cached revenue is $642.8M (FY2025).
Is TXG profitable?
10X Genomics Inc last cached net income is -$43.5M (FY2025).
What are TXG total assets?
10X Genomics Inc last cached total assets are $1.04B (FY2025).
What is TXG free cash flow?
10X Genomics Inc last cached free cash flow is $130.1M (FY2025).
Not investment advice. Cached statements, not a live tape.